Abstract
Numerous compounds with a benzothiazole scaffold that have been described in the literature show promising activities against several Gram-positive and Gramnegative bacteria, and also against Mycobacterium tuberculosis. Benzothiazole-based antibacterial compounds bind to different biological targets in bacterial cells and have been shown to be inhibitors of enzymes that are important for essential processes in the bacterial cells, such as cell-wall synthesis, cell division, and DNA replication, or are important for different biosynthetic pathways of essential compounds in bacterial cells, such as the biosynthesis of histidine and biotin. This review focuses on the antibacterial potential of benzothiazole-based compounds, in terms of their specific interactions with targets in bacterial cells. We assess the importance of the benzothiazole scaffold in the discovery of new antibacterial compounds, the potential of benzothiazole-based compounds against resistant bacterial strains, optimization of their antibacterial activity, and the future perspectives of benzothiazole-based antibacterials.
Keywords: Benzothiazole, antibacterial, antimycobacterial, bacterial resistance, molecular target, antibiofilm.
Current Medicinal Chemistry
Title:Benzothiazole-based Compounds in Antibacterial Drug Discovery
Volume: 25 Issue: 38
Author(s): Marina Gjorgjieva, Tihomir Tomašič, Danijel Kikelj and Lucija Peterlin Mašič*
Affiliation:
- University of Ljubljana, Faculty of Pharmacy, Askerceva 7, 1000 Ljubljana,Slovenia
Keywords: Benzothiazole, antibacterial, antimycobacterial, bacterial resistance, molecular target, antibiofilm.
Abstract: Numerous compounds with a benzothiazole scaffold that have been described in the literature show promising activities against several Gram-positive and Gramnegative bacteria, and also against Mycobacterium tuberculosis. Benzothiazole-based antibacterial compounds bind to different biological targets in bacterial cells and have been shown to be inhibitors of enzymes that are important for essential processes in the bacterial cells, such as cell-wall synthesis, cell division, and DNA replication, or are important for different biosynthetic pathways of essential compounds in bacterial cells, such as the biosynthesis of histidine and biotin. This review focuses on the antibacterial potential of benzothiazole-based compounds, in terms of their specific interactions with targets in bacterial cells. We assess the importance of the benzothiazole scaffold in the discovery of new antibacterial compounds, the potential of benzothiazole-based compounds against resistant bacterial strains, optimization of their antibacterial activity, and the future perspectives of benzothiazole-based antibacterials.
Export Options
About this article
Cite this article as:
Gjorgjieva Marina, Tomašič Tihomir , Kikelj Danijel and Mašič Peterlin Lucija *, Benzothiazole-based Compounds in Antibacterial Drug Discovery, Current Medicinal Chemistry 2018; 25 (38) . https://dx.doi.org/10.2174/0929867324666171009103327
DOI https://dx.doi.org/10.2174/0929867324666171009103327 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and In Vitro Antibacterial Screening of some New 2,4,6-Trisubstituted-1,3,5-Triazine Derivatives
Letters in Drug Design & Discovery Pyrimidine Salvage Pathway in Mycobacterium tuberculosis
Current Medicinal Chemistry Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry Editorial (Hot Topic: Cell Processes in Bacterial Diseases)
Protein & Peptide Letters A Facile and Efficient One-pot Three Component Route to New Bis(1,2,4- Oxadiazole) Linked with Polyoxyethylene Chain
Letters in Organic Chemistry Cationic Antimicrobial Peptides for Tuberculosis: A Mini-Review
Current Protein & Peptide Science Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression
Current HIV Research Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012?
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: The Lab-on-a-protein Concept Protein as Powerful Nanometric Laboratory for Chemical Sciences)
Current Organic Chemistry Repositioning of DHFR Inhibitors
Current Topics in Medicinal Chemistry Lipid-Drug Conjugates for Oral Bioavailability Enhancement
Recent Patents on Nanomedicine Design, Synthesis and In Vitro Biological Evaluation of Pyridine, Thiadazole, Benzimidazole and Acetyl Thiophene Analogues as Anti Tubercular Agents Targeting Enzyme Inh A
Current Computer-Aided Drug Design Patented Biomarkers of Peripheral Blood for the Early Detection of Cancer
Recent Patents on Biomarkers Operational Issues and Barriers to Implementation of Prevention of Mother-to-Child Transmission of HIV (PMTCT) Interventions in Sub- Saharan Africa
Current HIV Research Microarray Analysis of Whole Genome Expression of Intracellular Mycobacterium tuberculosis
Current Molecular Medicine Current Strategies in TB Immunotherapy
Current Molecular Medicine Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews The Role of Heat Shock Protein (HSP) in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Medicinal Chemistry Targeting Cancer: The Challenges and Successes of Structure-Based Drug Design Against the Human Purinome
Current Topics in Medicinal Chemistry Emerging Therapies in Relapsing-Remitting Multiple Sclerosis
Reviews on Recent Clinical Trials